JANA CHAVOUS: Open Payments
NPI 1942729546 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,553 in 63 payments from 19 companies in 2025. Trend: 2023 $678 · 2024 $709 · 2025 $1,553
Food & beverage: $1,351Education: $203
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $254 |
| Lilly USA, LLC | 5 | $251 |
| AstraZeneca Pharmaceuticals LP | 8 | $246 |
| Janssen Biotech, Inc. | 6 | $209 |
| ABBVIE INC. | 9 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Genentech USA, Inc. | 2 | $44 |
| Aveo Pharmaceuticals, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
Products named: EPKINLY, RYBREVANT, CALQUENCE, SCEMBLIX, KISQALI, VENCLEXTA, VERZENIO, ICLUSIG.
Industry payments across OK — which companies pay providers there.
